The Fly Blog | Talkmarkets | Page 1
Real-Time Financial News
Contributor's Links: TheFly.com

The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, ... more

All Contributions

Latest Posts
1 to 16 of 2934 Posts
1 2 3 ... 184
Credit Suisse Downgrades Zoom Video To Underperform On High Expectations
Credit Suisse analyst Brad Zelnick downgraded Zoom Video Communications (ZM) to Underperform from Neutral with a price target of $105, up from $95.
Tesla Upgraded To Buy From Hold At Jefferies
Jefferies analyst Philippe Houchois upgraded Tesla to Buy from Hold with a price target of $650, down from $800
Livent Upgraded To Market Perform From Underperform At BMO Capital
BMO Capital analyst Joel Jackson upgraded Livent to "Market Perform" from "Underperform," with a price target of $5.50, down from $7.50. The stock closed Friday, up 13 cents to $4.73.
Week In Review: How Trump's Policies Moved Stocks - Saturday, April 4
Trump "expects and hopes" Saudis, Russia agree to cut oil production by 10M barrels or "as high as 15 million barrels."
Baker Hughes Reports U.S. Rig Count Down 64 To 664 Rigs
Baker Hughes reports that the U.S. rig count is down 64 rigs from last week to 664, with oil rigs down 62 to 562, gas rigs down 2 to 100, and miscellaneous rigs unchanged at 2.
Immunomedics Downgraded To Sell From Buy At Goldman Sachs
Goldman Sachs analyst Paul Choi double downgraded Immunomedics to Sell from Buy with a price target of $5, down from $24.
Twitter Upgraded To Buy From Neutral At Goldman Sachs
Goldman Sachs analyst Heath Terry upgraded Twitter to Buy from Neutral with a price target of $35, down from $39.
Starbucks Rises As Chinese Competitor Luckin Probes Fraudulent Transactions
Back in January, short-seller Muddy Waters accused Luckin Coffee of both fraud and having a "fundamentally broken business".
Guggenheim Downgrades 'Particularly Hard Hit' Disney To Neutral
Guggenheim analyst Michael Morris downgraded Disney to Neutral from Buy with a price target of $100, down from $160.
Beyond Meat Price Target Lowered To $72 From $115 At Piper Sandler
Piper Sandler analyst Michael Lavery lowered the firm's price target on Beyond Meat to $72 from $115 and keeps a Neutral rating on the shares.
Barclays Warns Tesla Bears Narrative 'Could Swing Bullish' Near-Term
Despite significant pressures in Q2, Tesla's Q1 deliveries may beat the lowered consensus expectations of around 80,000, Barclays analyst Brian Johnson tells investors in a research note.
Zoom Shares Slip Following Reports Of Data Privacy, Security Issues
Intercept says Zoom meetings not actually end-to-end encrypted.
Oppenheimer Upgrades Amarin To Perform With Shares Poised For 70% Drop At Open
Oppenheimer analyst Leland Gershell upgraded Amarin to Perform from Underperform and removed his $12 price target, given the sharp decline expected in the stock this morning.
Amarin Should Not Be Bought On Selloff After 'Serious Blow,' Says Stifel
Stifel analyst Derek Archila lowered the firm's price target on Amarin to $8 from $24 and keeps a Hold rating on the shares.
Acadia Upgraded To Buy From Neutral At Goldman Sachs
Goldman Sachs analyst Salveen Richter upgraded Acadia Pharmaceuticals to Buy from Neutral with a price target of $72, up from $45.
Huazhu Group Upgraded To 'Buy' From 'Neutral' At Goldman Sachs
Goldman Sachs analyst Justin Kwok upgraded Huazhu Group to 'Buy' from 'Neutral,' with a price target of $38, down from $38.50.
1 to 16 of 2934 Posts
1 2 3 ... 184